Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Patrick McGrady"'
Autor:
John Patrick, McGrady, Yamashita, Shinichi, Kano, Sho, Yang, Huilong, Duan, Zhengang, Saito, Takumi, Abe, Hiroaki, patrick Mc grady, John, Atsushi, Kimura
Publikováno v:
Journal of Nuclear Science and Technology. 57(4):463-471
Typical metal oxide corrosion products of structural materials have been irradiated with γ-rays in ultra-pure water to investigate the effect of radiation on the surface oxide and the nature of adsorbed water. Analysis techniques including thermal g
Autor:
Patrick McGrady
Publikováno v:
Journal of homosexuality. 63(12)
Being gay and being overweight are two stigmatized statuses in the United States. A range of work has considered the experience of being stigmatized and the consequences of stereotypes for overweight individuals and sexual minorities, but less resear
Autor:
Robert C. Seeger, Xao X. Tang, Susan L. Cohn, Hiroyuki Shimada, John M. Maris, Wendy B. London, Rie Suganuma, Patrick McGrady, Naohiko Ikegaki, Larry Wang, Arlene Naranjo, A. Thomas Look, Michael D. Hogarty, Julie R Park, Julie M. Gastier-Foster
Publikováno v:
Cancer. 119:3718-3726
BACKGROUND This study sought to investigate biological/clinicopathological characteristics of neuroblastoma, undifferentiated subtype (NBUD). METHODS This study examined 157 NBUD cases filed at the Children's Oncology Group Neuroblastoma Pathology Re
Autor:
Barry L. Shulkin, Patrick McGrady, Gregory A. Yanik, Susan G. Kreissman, Julie R. Park, John M. Maris, Marguerite T. Parisi, Katherine K. Matthay, Wendy B. London, Arlene Naranjo, Judith G. Villablanca, Susan L. Cohn
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 54, iss 4
UnlabelledRadiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients
Autor:
Patrick McGrady, Nancy Bunin, Susan L. Cohn, John M. Maris, Lisa Diller, Cynthia Kretschmar, Julie R. Park, S A Grupp, Alix E. Seif, Wendy B. London, Arlene Naranjo, Morris Kletzel, D. von Allmen, David L. Baker
Publikováno v:
Bone marrow transplantation
Increasing treatment intensity has improved outcomes for children with neuroblastoma. We performed a pilot study in the Children’s Oncology Group (COG) to assess feasibility and toxicity of a tandem myeloablative regimen without total body irradiat
Autor:
Lisa Diller, Mary Lou Schmidt, John M. Maris, Patrick McGrady, James D. Geiger, Robert C. Shamberger, Wendy B. London, Jed G. Nuchtern, Arlene Naranjo, Susan L. Cohn, Carol E. Barnewolt
Publikováno v:
Annals of Surgery. 256:573-580
To demonstrate that expectant observation of young infants with small adrenal masses would result in excellent event-free and overall survival.Neuroblastoma is the most common malignant tumor in infants, and in young infants, 90% of neuroblastomas ar
Autor:
Garrett M. Brodeur, Wendy B. London, Patrick McGrady, Mayumi Higashi, Venkatadri Kolla, Tiangang Zhuang, Hiroshi Koyama, Jennifer E. Light
Publikováno v:
Clinical Cancer Research. 18:1588-1597
Purpose: Neuroblastomas (NBs) have genomic, biological, and clinical heterogeneity. High-risk NBs are characterized by several genomic changes, including MYCN amplification and 1p36 deletion. We identified the chromatin-remodeling gene CHD5 as a tumo
Autor:
Marguerite T. Parisi, Paul M. Sondel, Hollie A. Jackson, Brenda J. Kitchen, C. Patrick Reynolds, Enno Stranzinger, Wendy B. London, Barry L. Shulkin, Joel M. Reid, Sarah A. Buhrow, Gregory A. Yanik, Arlene Naranjo, Patrick McGrady, Judith G. Villablanca, Susan L. Cohn, Renee M. McGovern, Matthew M. Ames
Publikováno v:
Clinical Cancer Research. 17:6858-6866
Purpose: To determine the response rate to oral capsular fenretinide in children with recurrent or biopsy proven refractory high-risk neuroblastoma. Experimental Design: Patients received 7 days of fenretinide: 2,475 mg/m2/d divided TID ( Results: Si
Autor:
Gian Paolo Tonini, Jo Vandesompele, Wendy B. London, Genevieve Laureys, André Oberthuer, Matthias Fischer, Rosa Noguera, Adela Cañete, Jean Bénard, Peter F. Ambros, Bárbara Marques, Klaus Beiske, Patrick McGrady, Marta Piqueras, Arlene Naranjo, Liesbeth Vercruysse, Victoria Castel, Bruno De Bernardi, Sophie Bravo, J.A. Kohler, Jan Hellemans, Joëlle Vermeulen, Valreie Combaret, Paolo Scaruffi, Nadine Van Roy, Jean Michon, Hervé Rubie, Michael D. Hogarty, Olivier Delattre, Katrien Swerts, Katleen De Preter, Franki Speleman, Ruth Ladenstein, Isobelle Janoueix-Lerosey, Gudrun Schleiermacher, Ulrike Pötschger
Publikováno v:
The Lancet Oncology. 10:663-671
Summary Background More accurate prognostic assessment of patients with neuroblastoma is required to better inform the choice of risk-related therapy. The aim of this study is to develop and validate a gene-expression signature to improve outcome pre
Autor:
Kai Wang, Cecilia Kim, Kristina A. Cole, Jill E. Lynch, Jonathan P. Bradfield, Alexandra I. F. Blakemore, Patrick McGrady, Maura Diamond, Kristopher R. Bosse, Katlyn Pecor, Hakon Hakonarson, Marci Laudenslager, Sharon J. Diskin, Hongzhe Li, Cuiping Hou, Edward F. Attiyeh, John M. Maris, Cynthia Winter, Andrew Wood, Wendy B. London, Marcella Devoto, Yael P. Mosse, Tamim H. Shaikh, Struan F.A. Grant, Elizabeth A. Geiger, E. Rappaport, Joseph T. Glessner
Publikováno v:
Nature. 459:987-991
Copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) are two important potential sources of phenotypic variation in humans. Until now, only SNPs have been associated with cancer, but the increasing recognition that germline DNA do